Bank of America
EDVA

Bank of America’s Endovia Health Sciences, Inc. EDVA Stock Holding History

Bank of America’s Portfolio EDVA Stock Details EDVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-5
Closed -$13 – 6691
2025
Q4 		$13 Hold
5
– – ﹤0.01% 7179
2025
Q3 		$43 Buy
5
+2
+67% +$17 ﹤0.01% 8047
2025
Q2 		$49 Buy
3
+1
+50% +$16 ﹤0.01% 8109
2025
Q1 		$13 Hold
2
– – ﹤0.01% 8192
2024
Q4 		$62 Hold
2
– – ﹤0.01% 7832
2024
Q3 		$87 Buy
2
+1
+100% +$50 ﹤0.01% 7742
2024
Q2 		$53 Buy
+1
New +$47 ﹤0.01% 7827
2024
Q1 		– Hold
0
– -$26 – 8124
2023
Q4 		– Hold
0
– – – 7608
2023
Q1 		– Hold
0
– -$36 – 8212
2022
Q4 		– Hold
0
– – – 7862
2022
Q2 		– Hold
0
– – – 8328
2022
Q1 		– Hold
0
– – – 8688
2021
Q4 		– Hold
0
– – – 8585

Other funds holding EDVA

HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
STA
Summit Trail Advisors New York $7.95B AUM 26.49% 1-Year Est. Return
PM
Phraction Management Colchester, Connecticut $596M AUM 36.77% 1-Year Est. Return
LWM
Lifetime Wealth Management Rockwall, Texas $171M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
CL
Choreo LLC Rockford, Illinois $9.11B AUM 26.3% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Bank of America's EDVA Position: Q1 2026 in Review

Bank of America sold out of Endovia Health Sciences, Inc. (EDVA) in Q1 2026, closing a stake of 5 shares — an estimated $13 sold.

Bank of America first reported a position in EDVA in Q2 2024 and held it in 7 quarters. The position peaked at $87 in Q3 2024. 15 funds tracked by Wall St. Rank hold EDVA as of Q1 2026.

  • Bank of America reported no remaining Endovia Health Sciences, Inc. position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 5 Endovia Health Sciences, Inc. shares in Q1 2026, an estimated $13.
  • Bank of America first reported a position in Endovia Health Sciences, Inc. in Q2 2024 and held it in 7 quarters.
  • Bank of America's Endovia Health Sciences, Inc. position peaked at $87 in Q3 2024.
  • 15 funds tracked by Wall St. Rank held Endovia Health Sciences, Inc. as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.